Your browser doesn't support javascript.
COVID-19 clinical phenotypes and short-term outcomes: differences between the first and the second wave of pandemic in Italy.
Portacci, Andrea; Carpagnano, Giovanna Elisiana; Tummolo, Maria Grazia; Santomasi, Carla; Palma, Lavinia; Fasano, Domenico; Resta, Emanuela; Lozupone, Madia; Solfrizzi, Vincenzo; Panza, Francesco; Resta, Onofrio.
  • Portacci A; Institute of Respiratory Disease, Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari, "Aldo Moro", Bari, Italy.
  • Carpagnano GE; Institute of Respiratory Disease, Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari, "Aldo Moro", Bari, Italy.
  • Tummolo MG; Institute of Respiratory Disease, Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari, "Aldo Moro", Bari, Italy.
  • Santomasi C; Institute of Respiratory Disease, Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari, "Aldo Moro", Bari, Italy.
  • Palma L; Institute of Respiratory Disease, Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari, "Aldo Moro", Bari, Italy.
  • Fasano D; Medical Clinic "C. Frugoni" and Geriatric Medicine Unit, University of Bari "Aldo Moro", Bari, Italy.
  • Resta E; Translational Medicine and Health System Management, University of Foggia, Foggia, Italy.
  • Lozupone M; Neurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Solfrizzi V; Medical Clinic "C. Frugoni" and Geriatric Medicine Unit, University of Bari "Aldo Moro", Bari, Italy.
  • Panza F; Population Health Unit, "Salus in Apulia Study", National Institute of Gastroenterology "Saverio De Bellis", Research Hospital, Castellana Grotte, Bari, Italy.
  • Resta O; Institute of Respiratory Disease, Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari, "Aldo Moro", Bari, Italy.
Expert Rev Respir Med ; 15(12): 1619-1625, 2021 12.
Article in English | MEDLINE | ID: covidwho-1324535
ABSTRACT

Objectives:

There are no comparative studies between patients belonging to the first and second waves of the SARS-CoV-2 pandemic, the virus triggering coronavirus disease 2019 (COVID-19). In this retrospective observational study, we analyzed the clinical characteristics and the short-term outcomes of two groups of laboratory-confirmed COVID-19 patients with moderate-to-severe acute respiratory distress syndrome (ARDS) belonging to two different waves of the pandemic

Methods:

We analyzed 97 consecutive patients from 11 March 2020 to 31 May 2020 and 52 consecutive patients from 28 August 2020 to 15 October 2020. 

Results:

Patients belonging to the second wave were younger, had a lower number of concomitant chronic conditions (multimorbidity), and had a milder clinical phenotype. Medical treatments and respiratory support use have changed during the COVID-19 pandemic, based on different laboratory results and disease clinical features. Patients in the second wave had better short-term clinical outcomes, with lower death rates and more step-down transfers to a general ward

Conclusion:

The present findings show a clear phenotypic difference in patients hospitalized at different stages of the COVID-19 pandemic in Italy. These results can help to stratify clinical risk and to better tailor medical treatments and respiratory support for patients with ARDS and COVID-19 pneumonia.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Expert Rev Respir Med Year: 2021 Document Type: Article Affiliation country: 17476348.2021.1960824

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Expert Rev Respir Med Year: 2021 Document Type: Article Affiliation country: 17476348.2021.1960824